Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

Ruoxi Li, Dazheng Ling, Tongke Tang, Zhenghui Huang, Manjiong Wang, Fei Mao, Jin Zhu, Lubin Jiang, Jian Li, Xiaokang Li

PDF(2326 KB)
Chinese Chemical Letters ›› 2021, Vol. 32 ›› Issue (05) : 1660-1664. DOI: 10.1016/j.cclet.2020.12.023
Communications

Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 32(05): 1660-1664 https://doi.org/10.1016/j.cclet.2020.12.023

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2326 KB)

Accesses

Citation

Detail

Sections
Recommended

/